64 related articles for article (PubMed ID: 16935784)
1. [Towards an individualization of systemic treatment of breast tumors].
Bernard-Marty C; Cardoso F; Sotiriou C; Piccart MJ
Bull Cancer; 2006 Aug; 93(8):791-7. PubMed ID: 16935784
[TBL] [Abstract][Full Text] [Related]
2. Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
[TBL] [Abstract][Full Text] [Related]
3. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
4. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
6. A six-gene signature predicting breast cancer lung metastasis.
Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
[TBL] [Abstract][Full Text] [Related]
7. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
8. Biomarker investigations from the ATAC trial: the role of TA01.
Dowsett M
Breast Cancer Res Treat; 2004; 87 Suppl 1():S11-8. PubMed ID: 15597216
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
; Tanner M; Isola J; Wiklund T; Erikstein B; Kellokumpu-Lehtinen P; Malmström P; Wilking N; Nilsson J; Bergh J
J Clin Oncol; 2006 Jun; 24(16):2428-36. PubMed ID: 16682728
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of breast axillary lymph node metastasis.
Cavalli LR
Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.
Andre F; Pusztai L
Nat Clin Pract Oncol; 2006 Nov; 3(11):621-32. PubMed ID: 17080180
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
13. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
14. [The value of gene expression profiles using micoarrays for the individualisation of adjuvant therapy after surgery for breast cancer].
Klijn JG; de Vries EG
Ned Tijdschr Geneeskd; 2005 Mar; 149(12):618-22. PubMed ID: 15813427
[TBL] [Abstract][Full Text] [Related]
15. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
16. Microarrays in breast cancer research and clinical practice--the future lies ahead.
Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
[TBL] [Abstract][Full Text] [Related]
17. A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
Kominsky SL; Davidson NE
J Clin Oncol; 2006 May; 24(15):2227-9. PubMed ID: 16636338
[No Abstract] [Full Text] [Related]
18. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.
von Minckwitz G; Untch M; Nüesch E; Loibl S; Kaufmann M; Kümmel S; Fasching PA; Eiermann W; Blohmer JU; Costa SD; Mehta K; Hilfrich J; Jackisch C; Gerber B; du Bois A; Huober J; Hanusch C; Konecny G; Fett W; Stickeler E; Harbeck N; Müller V; Jüni P
Breast Cancer Res Treat; 2011 Jan; 125(1):145-56. PubMed ID: 21042932
[TBL] [Abstract][Full Text] [Related]
19. Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen.
Campone M; Campion L; Roché H; Gouraud W; Charbonnel C; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Jézéquel P
Breast Cancer Res Treat; 2008 Jun; 109(3):491-501. PubMed ID: 17659439
[TBL] [Abstract][Full Text] [Related]
20. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
